{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:40:49Z","timestamp":1758818449434},"reference-count":29,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1989,3]]},"abstract":"<jats:p content-type=\"fine-print\">\u2713 Cell proliferation potential was assessed by measuring the labeling indices of the monoclonal antibody Ki-67 and of 5-bromodeoxyuridine (BUdR), and the cellular deoxyribonucleic acid (DNA) content in 48 human brain tumors. The diagnostic and prognostic value of flow-cytometric DNA analysis was also evaluated using ethanol-fixed paraffin-embedded BUdR-labeled specimens; these were the same specimens as were used for measuring the BUdR and Ki-67 labeling indices. Both the Ki-67 and the BUdR labeling indices correlated with the degree of malignancy estimated from conventional histological preparations. The Ki-67 labeling index was 1.7 times greater than the BUdR labeling index. The relationship of DNA aneuploidy to the labeling indices or to morphology in cases of glioma was examined. All of the tumors with an aneuploid line corresponded to malignant glioma classified by histological criteria, although malignant glioma did not always show DNA aneuploidy. In addition, the cases with aneuploid lines showed high BUdR and Ki-67 labeling indices. The cell kinetic data, which indicate the biological character of tumors, allowed prediction of the prognosis of the patients with gliomas. In contrast, despite the presence of an aneuploid line, three of 13 meningiomas showed a benign histological pattern without an aggressive clinical course, and neither the Ki-67 nor the BUdR labeling index was high. These results indicate an unequivocal relationship between DNA aneuploidy and clinical behavior; in general, both labeling indices may prove to be objective indicators of the outcome of patients with brain tumors.<\/jats:p>","DOI":"10.3171\/jns.1989.70.3.0379","type":"journal-article","created":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T16:21:27Z","timestamp":1241799687000},"page":"379-384","source":"Crossref","is-referenced-by-count":83,"title":["Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors"],"prefix":"10.3171","volume":"70","author":[{"given":"Takafumi","family":"Nishizaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Orita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Furutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihide","family":"Ikeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohsuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Am J Surg Pathol","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/00000478-198609000-00003","article-title":"The use of the monoclonal antibody Ki-67 in the identification of proliferating cells. Application to surgical neuropathology.","volume":"10","author":"Burger","year":"1986"},{"key":"b2","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3171\/jns.1986.65.6.0790","article-title":"Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling.","volume":"65","author":"Cho","year":"1986"},{"key":"b3","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF00684806","article-title":"DNA content of meningiomas.","volume":"46","author":"Frederiksen","year":"1979"},{"key":"b4","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF00690432","article-title":"Row cytometry in tumours of the brain.","volume":"41","author":"Frederiksen","year":"1978"},{"key":"b5","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/1097-0142(19861201)58:11<2453::AID-CNCR2820581117>3.0.CO;2-I","article-title":"Flow cytometric DNA analysis of neuroblastoma. Correlation with histology and clinical outcome.","volume":"58","author":"Gansler","year":"1986"},{"key":"b6","series-title":"Int J Cancer","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/ijc.2910350205","article-title":"An immunohistological method for estimating cell growth fractions in rapid histopathological diagnosis during surgery.","volume":"35","author":"Gerdes","year":"1985"},{"key":"b7","series-title":"Hematol Oncol","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/hon.2900020406","article-title":"Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67.","volume":"2","author":"Gerdes","year":"1984"},{"key":"b8","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF00692849","article-title":"Growth fraction in human brain tumor defined by the monoclonal antibody Ki-67.","volume":"74","author":"Giangaspero","year":"1987"},{"key":"b9","series-title":"Science","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1126\/science.7123245","article-title":"Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication.","volume":"218","author":"Gratzner","year":"1982"},{"key":"b10","series-title":"Cytometry","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/cyto.990060409","article-title":"Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.","volume":"6","author":"Hedley","year":"1985"},{"key":"b11","series-title":"J Histochem Cytochem","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1177\/31.11.6619538","article-title":"Method for analysis of cellular DNA content of paraffin-embedded pathological materials using flow cytometry.","volume":"31","author":"Hedley","year":"1983"},{"key":"b12","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/1097-0142(19820901)50:5<997::AID-CNCR2820500530>3.0.CO;2-W","article-title":"Clonogenicity of multiple populations of human glioma cells in vitro sorted by DNA content.","volume":"50","author":"Hoshino","year":"1982"},{"key":"b13","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3171\/jns.1986.64.3.0453","article-title":"In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.","volume":"64","author":"Hoshino","year":"1986"},{"key":"b14","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3171\/jns.1978.49.1.0013","article-title":"The distribution of nuclear DNA from human brain-tumor cells. Flow cytometric studies.","volume":"49","author":"Hoshino","year":"1978"},{"key":"b15","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3171\/jns.1987.66.4.0588","article-title":"DNA in meningioma tissues and explant cell cultures. A flow cytometric study with clinicopathological correlates.","volume":"66","author":"Ironside","year":"1987"},{"key":"b16","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF00684802","article-title":"Flow cytometric analysis of the DNA distribution in human brain tumors.","volume":"46","author":"Kawamoto","year":"1979"},{"key":"b17","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1056\/NEJM198407263110405","article-title":"Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma.","volume":"311","author":"Look","year":"1984"},{"key":"b18","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3171\/jns.1980.53.2.0198","article-title":"Model DNA content of human intracranial neoplasms studied by flow cytometry.","volume":"53","author":"M\u00f8rk","year":"1980"},{"key":"b19","series-title":"J Clin Invest","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1172\/JCI111145","article-title":"Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.","volume":"72","author":"Morstyn","year":"1983"},{"key":"b20","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1227\/00006123-198612000-00003","article-title":"Pediatric central nervous system tumors: a cell kinetic study with bromodeoxyuridine.","volume":"19","author":"Murovic","year":"1986"},{"key":"b21","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3171\/jns.1986.64.4.0588","article-title":"The proliferative potential of human pituitary tumors in situ.","volume":"64","author":"Nagashima","year":"1986"},{"key":"b22","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3171\/jns.1988.69.3.0371","article-title":"Cell kinetics studies of human brain tumors by in vitro labeling using anti-BUdR monoclonal antibody.","volume":"69","author":"Nishizaki","year":"1988"},{"key":"b23","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF00688260","article-title":"Proliferative potential of meningiomas determined with the monoclonal antibody Ki-67.","volume":"73","author":"Roggendorf","year":"1987"},{"key":"b24","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/1097-0142(19881215)62:12<2569::AID-CNCR2820621220>3.0.CO;2-0","article-title":"Intratumoral regional differences in DNA ploidy of gastro-intestinal carcinomas.","volume":"62","author":"Sasaki","year":"1988"},{"key":"b25","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/1097-0142(19880901)62:5<989::AID-CNCR2820620525>3.0.CO;2-U","article-title":"Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors.","volume":"62","author":"Sasaki","year":"1988"},{"key":"b26","series-title":"Stain Technol","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/10520298609110726","article-title":"Immunological determination of labeling index on human tumor tissue sections using monoclonal anti-BrdUrd antibody.","volume":"61","author":"Sasaki","year":"1986"},{"key":"b27","series-title":"Cytometry","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/cyto.990060106","article-title":"Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue.","volume":"6","author":"Schutte","year":"1985"},{"key":"b28","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/1097-0142(19880215)61:4<744::AID-CNCR2820610418>3.0.CO;2-M","article-title":"Flow cytometric DNA analysis of medulloblastoma. Prognostic implication of aneuploidy.","volume":"61","author":"Tomita","year":"1988"},{"key":"b29","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1227\/00006123-198802000-00015","article-title":"Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.","volume":"22","author":"Zuber","year":"1988"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/70\/3\/article-p379.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/70\/3\/article-p379.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/70\/3\/article-p379.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:14:58Z","timestamp":1679876098000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/70\/3\/article-p379.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,3]]},"references-count":29,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/jns.1989.70.3.0379","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[1989,3]]}}}